A Waiting Room-Delivered Video to Enhance Clinical Outcomes Among Persons Living With HIV
TCOM
1 other identifier
interventional
4,003
0 countries
N/A
Brief Summary
The purpose of this project is to beta-test a brief waiting room video intervention that promotes early initiation of antiretroviral treatment among treatment-naïve HIV-positive patients, adherence to antiretroviral treatment and retention in care among HIV-positive patients currently on therapy, sexual risk reduction tailored to HIV-positive persons, and patient-initiated discussion of these topics with their health providers. The video is currently being created, and will be ready for beta-testing by June 1, 2016. Results of the beta-testing will be used to refine and improve the video before dissemination to HIV/AIDS treatment facilities nationally. This video project is being funded by the Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention (DHAP).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hiv-infections
Started Jun 2016
Shorter than P25 for not_applicable hiv-infections
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 17, 2017
CompletedFirst Submitted
Initial submission to the registry
April 16, 2018
CompletedFirst Posted
Study publicly available on registry
April 25, 2018
CompletedSeptember 17, 2025
September 1, 2025
10 months
April 16, 2018
September 15, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Antiretroviral therapy (ART) medication adherence (suppression level)
Adherence was measured by whether viral load suppression (\<200 RNA copies/mL) was achieved
By 6 months (183 days) after the patient's index (first) visit to the clinic
Antiretroviral therapy (ART) medication adherence (undetectable level)
Adherence was measured by whether viral load suppression (\<50 RNA copies/mL) was achieved
By 6 months (183 days) after the patient's index (first) visit to the clinic
Secondary Outcomes (2)
Treatment initiation
on, before, or within 7 days after, their index visit, as documented by OAMC visits in patient EMRs.
Retention in HIV medical care
2 or more clinic visits for any reason at least 90 days apart in the past year divided by all active clients who had had at least one such visit in the past year
Study Arms (2)
Intervention
EXPERIMENTAL29-minute clinic waiting room video intervention that includes three vignettes and a 2-part animation sequence about main characters who model overcoming challenges to optimal HIV care. The video was played on continuous loop in recognition of typically short patient wait times. Waiting room posters used images from the video to direct patients' attention to the video and reinforce prevention messages.
Comparison
NO INTERVENTIONHistorical comparison condition. Patients were exposed to standard waiting room environment (absent of intervention video and posters).
Interventions
The video's conceptual framework incorporates Social Cognitive Theory, Information-Motivation-Behavioral Skills model, and Social Action Theory, which together address cognitive and behavioral factors related to study outcomes. Storylines embedded prevention messages aimed at increasing treatment initiation (n=9), medication adherence (n=35), retention in care (n=22), partner protection (n=12), and communication with health care providers (n=7).
Eligibility Criteria
You may qualify if:
- located in a jurisdiction with high AIDS prevalence;
- managing more than 500 unique HIV-positive patients annually;
- serving minority persons such that minimally 55% of the clinic population is African-American and Hispanic/Latino;
- at least 163 patients have unsuppressed viral load;
- utilizing an electronic medical record (EMR) system; and
- not participating in another behavioral intervention research project during the historical comparison data period (August 2015 through May 2016) or during the 10-month intervention period (June 2016 through March 2017).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centers for Disease Control and Preventionlead
- Sentient Researchcollaborator
- UCLA David Geffen School of Medicine and Fielding School of Public Healthcollaborator
- Denver STD Prevention Training Center, Denver Public Health Departmentcollaborator
- California State University, Long Beachcollaborator
- Education Development Center, Inc.collaborator
Related Publications (1)
Neumann MS, Plant A, Margolis AD, Borkowf CB, Malotte CK, Rietmeijer CA, Flores SA, O'Donnell L, Robilotto S, Myint-U A, Montoya JA, Javanbakht M, Klausner JD. Effects of a brief video intervention on treatment initiation and adherence among patients attending human immunodeficiency virus treatment clinics. PLoS One. 2018 Oct 5;13(10):e0204599. doi: 10.1371/journal.pone.0204599. eCollection 2018.
PMID: 30289884DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary S. Neumann, PhD
Centers for Disease Control and Prevention
- PRINCIPAL INVESTIGATOR
Aaron Plant, MPH
Sentient Research
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 16, 2018
First Posted
April 25, 2018
Study Start
June 1, 2016
Primary Completion
March 30, 2017
Study Completion
May 17, 2017
Last Updated
September 17, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
- Time Frame
- To be determined
- Access Criteria
- To be determined
When appropriate, data sets will be made available to interested researchers following discussion with study team.